Beta2-Microglobulin Production by Highly Purified Human T and B Lymphocytes in Cell Culture Stimulated with Various Mitogens
Overview
Authors
Affiliations
This study attempts to evaluate beta2-microglobulin production by highly purified (greater than 98%) peripheral and tonsil T and B lymphocytes cultured with various mitogens. beta2-Microglobulin was measured by the radioimmunoassay method. It was found that PHA and Con A markedly stimulated beta2-microglobulin production in cultures of T but not B lymphocytes. B lymphocytes were greatly activated, on the other hand, by Staphylococcus aureau Cowan I organisms cSpA), though the level of beta2-microglobulin production was less than that observed in PHA- and Con A-stimulated T lymphocytes. PWM only slightly increased beta2-microglobulin production of T lymphocytes, although the incorporation of [3H]-thymidine was highly enhanced. The highest level of beta2-microglobulin obtained with PHA or Con A was observed when the T/B lymphocyte ratio was between 90/10 and 80/20. These results lead to the conclusion that: (1) SpA is a specific mitogen for B lymphocytes, and its mitogenicity is independent of the presence of T lymphocytes, while PHA, Con A, and PWM are ineffective as stimulants of B lymphocytes; (2) the beta2-microglobulin producing ability of B lymphocytes is less than that of T lymphocytes, even when the lymphocytes are markedly activated; (3) the beta2-microglobulin production and DNA synthesis by T lymphocytes is markedly enhanced by the helper effect of B lymphocytes; (4) the level of beta2-microglobulin production reflects lymphocyte activation, especially in T lymphocytes stimulated with PHA or Con A.
The Role of Beta2-Microglobulin in Central Nervous System Disease.
Liu Z, Tang F, Yang J, Chen X, Wang Z, Li Z Cell Mol Neurobiol. 2024; 44(1):46.
PMID: 38743119 PMC: 11093819. DOI: 10.1007/s10571-024-01481-6.
Maruyama Y, Nakayama M, Abe M, Yokoo T, Minakuchi J, Nitta K PLoS One. 2022; 17(4):e0266882.
PMID: 35421178 PMC: 9009671. DOI: 10.1371/journal.pone.0266882.
Gene Expression Profiling in Multiple Myeloma: Redefining the Paradigm of Risk-Adapted Treatment.
Cerchione C, Usmani S, Stewart A, Kaiser M, Rasche L, Kortum M Front Oncol. 2022; 12:820768.
PMID: 35211412 PMC: 8861274. DOI: 10.3389/fonc.2022.820768.
Azuma J, Yamamoto T, Sakurai M, Amou R, Yamada C, Hashimoto K Medicine (Baltimore). 2018; 97(43):e12930.
PMID: 30412100 PMC: 6221734. DOI: 10.1097/MD.0000000000012930.
Biomarkers for Bronchopulmonary Dysplasia in the Preterm Infant.
Rivera L, Siddaiah R, Oji-Mmuo C, Silveyra G, Silveyra P Front Pediatr. 2016; 4:33.
PMID: 27065351 PMC: 4814627. DOI: 10.3389/fped.2016.00033.